retatrutide clinical data Eli Lilly infiltrates anti-obesity market as Phase III trial for begins Retatrutide 3-Month Results: Weight Loss

Motus is a compelling oral, evidencebacked option for people who prefer pills to injections and value a researchdriven supplement approach

The Outsourcing Facilities Association submitted a comment to the FDA estimating that compounding pharmacies filled roughly 80 million prescriptions for semaglutide in the last 12 months, The Washington Post reported

Market research of GLP-1Rx patients cited by the company found 95% adhered to the medication, while 84% of prescribed patients engaged with in-app content and 56% used the apps Med Tracker (where side effects can also be tracked)

It's also important to note that GLP-1 medications are not recommended during pregnancy or breastfeeding, and women of childbearing potential should follow product-specific advice regarding discontinuation before planned pregnancy

Published : Medically Reviewed by Dr Lilla Csonka : June 06, 2026 Written by Jordan Caulfield & Reviewed by Paul Holmes